Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers

Clinical trial NCT03749460 · COMPLETED

Trial details

NCT number: NCT03749460
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm in the Bone Metastatic Malignant Neoplasm in the Lung Salivary Gland Carcinoma Stage IV Major Salivary Gland Cancer AJCC v8 Stage IVA Major Salivary Gland Cancer AJCC v8 Stage IVB Major Salivary Gland Cancer AJCC v8 Stage IVC Major Salivary Gland Cancer AJCC v8

Start date: 2019-01-15
Primary completion: 2022-11-05
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.